Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 865 in its research report dated February 17, 2023.
YES Securities is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 16, 2023.
Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1000 in its research report dated December 28, 2022.
The return of the flu season in India and the US, and COVID-19 in China sparked more investor interest in the sector.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 950 in its research report dated November 15, 2022.
Choice Equity Broking recommended Neutral rating on Ipca Laboratories with a target price of Rs 908 in its research report dated November 15, 2022.
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 925 in its research report dated November 15, 2022.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1000 in its research report dated September 29, 2022.
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 985 in its research report dated August 13, 2022.
Prabhudas Lilladher recommended hold rating on Ipca Laboratories with a target price of Rs 1010 in its research report dated August 12, 2022.
Sharekhan recommended Hold rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated August 11, 2022.
Traction in domestic business but uncertainty in export side
Motilal Oswal is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated June 22, 2022.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated May 26, 2022.
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 1000 in its research report dated May 26, 2022.
Sharekhan recommended Hold rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated May 25, 2022.
Ipca is adding 1200 medical representatives with a focus on Ortho, Derma, and Cardiovascular therapies
Motilal Oswal is bullish on Ipca Labs recommended buy rating on the stock with a target price of Rs 1200 in its research report dated March 11, 2022.
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1175 in its research report dated February 18, 2021.
Sharekhan is bullish on IPCA Laboratories has recommended buy rating on the stock with a target price of Rs 1160 in its research report dated February 15, 2022.
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1190 in its research report dated February 15, 2022.
Emkay Global Financial recommended hold rating on IPCA Laboratories with a target price of Rs 1060 in its research report dated February 15, 2022.
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1225 in its research report dated February 16, 2022.
Ipca lab's key challenge with respect to APIs is on the mend.
Edelweiss Securities is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2530 in its research report dated December 02, 2021.